Blondel Hazel

Array ( [id] => 2344940 [patent_doc_number] => 04656136 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-07 [patent_title] => 'Method for producing L-aspartic acid' [patent_app_type] => 1 [patent_app_number] => 6/591532 [patent_app_country] => US [patent_app_date] => 1984-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4920 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/656/04656136.pdf [firstpage_image] =>[orig_patent_app_number] => 591532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2449569 [patent_doc_number] => 04758524 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1988-07-19 [patent_title] => 'Monoclonal antibodies with specificity for crosslinked fibrin derivatives and assay for said derivatives' [patent_app_type] => 1 [patent_app_number] => 6/590054 [patent_app_country] => US [patent_app_date] => 1984-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8755 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/758/04758524.pdf [firstpage_image] =>[orig_patent_app_number] => 590054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2336185 [patent_doc_number] => 04711842 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-12-08 [patent_title] => 'Method for production of biologically active substances' [patent_app_type] => 1 [patent_app_number] => 6/589832 [patent_app_country] => US [patent_app_date] => 1984-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5840 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/711/04711842.pdf [firstpage_image] =>[orig_patent_app_number] => 589832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2340192 [patent_doc_number] => 04713342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-12-15 [patent_title] => 'Novel isolate of trichoderma, fungicidal compositions containing said isolate and use thereof' [patent_app_type] => 1 [patent_app_number] => 6/588950 [patent_app_country] => US [patent_app_date] => 1984-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4404 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/713/04713342.pdf [firstpage_image] =>[orig_patent_app_number] => 588950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2361887 [patent_doc_number] => 04658018 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-14 [patent_title] => 'Process for producing homogeneous colony stimulating factor' [patent_app_type] => 1 [patent_app_number] => 6/588940 [patent_app_country] => US [patent_app_date] => 1984-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5601 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/658/04658018.pdf [firstpage_image] =>[orig_patent_app_number] => 588940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2309274 [patent_doc_number] => 04675291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-06-23 [patent_title] => 'Human cultured cell line' [patent_app_type] => 1 [patent_app_number] => 6/586558 [patent_app_country] => US [patent_app_date] => 1984-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 6101 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/675/04675291.pdf [firstpage_image] =>[orig_patent_app_number] => 586558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2347413 [patent_doc_number] => 04692331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-09-08 [patent_title] => 'Gamma-globulin preparation for intravenous administration' [patent_app_type] => 1 [patent_app_number] => 6/583268 [patent_app_country] => US [patent_app_date] => 1984-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1798 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/692/04692331.pdf [firstpage_image] =>[orig_patent_app_number] => 583268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2270737 [patent_doc_number] => 04565781 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1986-01-21 [patent_title] => 'Antibiotic, Spicamycin' [patent_app_type] => 1 [patent_app_number] => 6/583108 [patent_app_country] => US [patent_app_date] => 1984-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3612 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 256 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/565/04565781.pdf [firstpage_image] =>[orig_patent_app_number] => 583108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2199043 [patent_doc_number] => 04533549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1985-08-06 [patent_title] => 'Antithrombotic agent' [patent_app_type] => 1 [patent_app_number] => 6/580761 [patent_app_country] => US [patent_app_date] => 1984-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2856 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/533/04533549.pdf [firstpage_image] =>[orig_patent_app_number] => 580761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2297197 [patent_doc_number] => 04681762 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-07-21 [patent_title] => 'Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype' [patent_app_type] => 1 [patent_app_number] => 6/580588 [patent_app_country] => US [patent_app_date] => 1984-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8434 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/681/04681762.pdf [firstpage_image] =>[orig_patent_app_number] => 580588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2316959 [patent_doc_number] => 04689220 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-08-25 [patent_title] => 'Immunization by immunogenic implant' [patent_app_type] => 1 [patent_app_number] => 6/580856 [patent_app_country] => US [patent_app_date] => 1984-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2330 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/689/04689220.pdf [firstpage_image] =>[orig_patent_app_number] => 580856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2361882 [patent_doc_number] => 04658017 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-04-14 [patent_title] => 'Method for the large scale purification of human fibroblast interferon' [patent_app_type] => 1 [patent_app_number] => 6/579994 [patent_app_country] => US [patent_app_date] => 1984-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3863 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/658/04658017.pdf [firstpage_image] =>[orig_patent_app_number] => 579994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2516419 [patent_doc_number] => 04870026 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1989-09-26 [patent_title] => 'Non-A, non-B. hepatitis, virus, methods of identification purification, characterization, diagnosis and immunization' [patent_app_type] => 1 [patent_app_number] => 6/577324 [patent_app_country] => US [patent_app_date] => 1984-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 13818 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/870/04870026.pdf [firstpage_image] =>[orig_patent_app_number] => 577324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2323048 [patent_doc_number] => 04680175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-07-14 [patent_title] => 'Interferon administration vehicles' [patent_app_type] => 1 [patent_app_number] => 6/577911 [patent_app_country] => US [patent_app_date] => 1984-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8329 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/680/04680175.pdf [firstpage_image] =>[orig_patent_app_number] => 577911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2310538 [patent_doc_number] => 04645757 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1987-02-24 [patent_title] => 'Agent for preventing or treating infections in human beings and animals' [patent_app_type] => 1 [patent_app_number] => 6/575160 [patent_app_country] => US [patent_app_date] => 1984-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5474 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/645/04645757.pdf [firstpage_image] =>[orig_patent_app_number] => 575160 [rel_patent_id] =>[rel_patent_doc_number] =>)